<DOC>
	<DOCNO>NCT02674594</DOCNO>
	<brief_summary>The overall objective proposal execute real-world database analysis evaluate hospital readmission among hospitalized nonvalvular atrial fibrillation ( NVAF ) patient U.S Primary objective : To determine proportion NVAF patient bleeding-related hospital readmission occur within 30 day hospitalization NVAF patient treat new oral anticoagulant ( NOACs ) , dabigatran , rivaroxaban , apixaban warfarin inpatient set Secondary objective : - To determine cost associate bleeding-related hospital readmission occur within 30 day hospitalization NVAF patient treat dabigatran , rivaroxaban , apixaban warfarin inpatient set - To determine proportion NVAF patient cause hospital readmission associate cost occur within 30 day hospitalization NVAF patient treat dabigatran , rivaroxaban , apixaban warfarin inpatient setting .</brief_summary>
	<brief_title>Evaluation Hospital Readmissions Among Hospitalized Non-valvular Atrial Fibrillation ( NVAF ) Patients US</brief_title>
	<detailed_description />
	<mesh_term>Atrial Fibrillation</mesh_term>
	<mesh_term>Apixaban</mesh_term>
	<mesh_term>Rivaroxaban</mesh_term>
	<mesh_term>Dabigatran</mesh_term>
	<mesh_term>Warfarin</mesh_term>
	<criteria>Have primary secondary diagnosis AF identify International Classification Diseases , Ninth Revision , Clinical Modification ( ICD9CM ) cod Premier Hospital database January 1 , 2012 December 31 , 2013 Age 18 year old initial hospitalization AF diagnosis Have primary secondary diagnosis code procedure code valvular disease study period . This exclusion criterion consistent use previous BMS HEOR study use ensure study population NVAF patient Received multiple type NOACs index hospitalization . Preliminary analysis show patient receive multiple type new oral anticoagulant ( NOACs ) hospitalization . This exclusion criterion allow cleanly group patient different NOAC usage group</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2016</verification_date>
	<keyword>Anticoagulation</keyword>
</DOC>